speb/financial-data huggingface dataset:
MD cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -7464000.00
MD cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 662000.00
MD cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 0.00
MD balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 30538000.00
MD balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 590476000.00
MD balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 621014000.00
MD cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 0.00
MD cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -5027000.00
MD cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: 0.00
MD cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -907000.00
MD balance_sheet (quarterly, 2025-03-31) — Net Debt: 513626000.00
MD income_statement (quarterly, 2025-03-31) — Net Income: 20737000.00
MD income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 20737000.00
MD income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 20737000.00
MD income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 20737000.00
MD income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 20737000.00
MD cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 20737000.00
MD income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 20737000.00
MD income_statement (quarterly, 2025-03-31) — Net Interest Income: -9154000.00
MD cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: -461000.00
MD cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -5027000.00
MD cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -5027000.00
MD income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -9154000.00
MD cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -101000.00
MD cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: -3685000.00
MD balance_sheet (quarterly, 2025-03-31) — Net PPE: 78088000.00
MD cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -3318000.00
MD balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: -463805000.00
MD balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 99379000.00
MD balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 34424000.00
MD balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 99379000.00
MD balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 34424000.00
MD income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 44444000.00
MD income_statement (quarterly, 2025-03-31) — Normalized Income: 22115584.00
MD cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -117463000.00
MD income_statement (quarterly, 2025-03-31) — Operating Income: 38706000.00
MD income_statement (quarterly, 2025-03-31) — Operating Revenue: 454562000.00
MD balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 85810408.00
MD balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 7608000.00
MD balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 22128000.00
MD balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -292000.00
MD income_statement (quarterly, 2025-03-31) — Other Gand A: 58604000.00
MD income_statement (quarterly, 2025-03-31) — Other Income Expense: -1462000.00
MD balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 10387000.00
MD cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: -528000.00
MD balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 71349000.00
MD balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 277801000.00
MD balance_sheet (quarterly, 2025-03-31) — Other Properties: 78088000.00
MD balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 120198000.00
MD balance_sheet (quarterly, 2025-03-31) — Payables: 72072000.00
MD balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 236750000.00
MD balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
MD balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 12085000.00
MD income_statement (quarterly, 2025-03-31) — Pretax Income: 28090000.00
MD cash_flow (quarterly, 2025-03-31) — Purchase Of Business: 0.00
MD cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -7761000.00
MD cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -3318000.00
MD balance_sheet (quarterly, 2025-03-31) — Receivables: 252801000.00
MD income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 355717000.00
MD income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 5332000.00
MD cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -5027000.00
MD cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -1569000.00
MD income_statement (quarterly, 2025-03-31) — Restructuring And Mergern Acquisition: 6605000.00
MD balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -227803000.00
MD cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 7300000.00
MD income_statement (quarterly, 2025-03-31) — Selling General And Administration: 58604000.00
MD balance_sheet (quarterly, 2025-03-31) — Share Issued: 85810408.00
MD income_statement (quarterly, 2025-03-31) — Special Income Charges: -6605000.00
MD cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 3641000.00
MD balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 789188000.00
MD balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: -463805000.00
MD income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -489416.00
MD income_statement (quarterly, 2025-03-31) — Tax Provision: 7353000.00
MD income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.26
MD balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 10272000.00
MD balance_sheet (quarterly, 2025-03-31) — Total Assets: 1993479000.00
MD balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 1379664000.00
MD balance_sheet (quarterly, 2025-03-31) — Total Debt: 655316000.00
MD balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 789188000.00
MD income_statement (quarterly, 2025-03-31) — Total Expenses: 419653000.00
MD balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 1204291000.00
MD balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 1501809000.00
MD balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 933239000.00
MD income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 32101000.00
MD balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 27952000.00
MD income_statement (quarterly, 2025-03-31) — Total Unusual Items: -1868000.00
MD income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -1868000.00
MD balance_sheet (quarterly, 2025-03-31) — Working Capital: 220618000.00
MD income_statement (quarterly, 2025-06-30) — +Operating Expense: 61027000.00
MD income_statement (quarterly, 2025-06-30) — +Total Revenue: 468844000.00
MD balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 42065000.00
MD balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 238992000.00
MD balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 1021290000.00
MD income_statement (quarterly, 2025-06-30) — Basic Average Shares: 86854234.00
MD income_statement (quarterly, 2025-06-30) — Basic EPS: 0.45
MD cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 98978000.00
MD cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -4515000.00
MD balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 42012000.00
MD balance_sheet (quarterly, 2025-06-30) — Capital Stock: 869000.00
MD balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 224732000.00
MD balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 348326000.00
MD cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -4259000.00
MD cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -7154000.00
MD cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 138131000.00
MD cash_flow (quarterly, 2025-06-30) — Cash From Discontinued Operating Activities: -964000.00
MD cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 69734000.00
MD cash_flow (quarterly, 2025-06-30) — Change In Income Tax Payable: 2015000.00
MD cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: 4952000.00
MD cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -3742000.00
MD cash_flow (quarterly, 2025-06-30) — Change In Payable: 71749000.00
MD cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 71749000.00
MD cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 1329000.00
MD cash_flow (quarterly, 2025-06-30) — Change In Receivables: 3770000.00
MD cash_flow (quarterly, 2025-06-30) — Change In Tax Payable: 2015000.00
MD cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 78058000.00
MD cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: 3770000.00
MD cash_flow (quarterly, 2025-06-30) — Changes In Cash: 125754000.00
MD balance_sheet (quarterly, 2025-06-30) — Common Stock: 869000.00
MD balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 833753000.00
MD cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 1176000.00
MD cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -209000.00
MD income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 344116000.00
MD balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 229918000.00
MD balance_sheet (quarterly, 2025-06-30) — Current Assets: 613050000.00
MD balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 12049000.00
MD balance_sheet (quarterly, 2025-06-30) — Current Debt: 23685000.00
MD balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 35734000.00
MD balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 341043000.00
MD cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: 12106000.00
MD cash_flow (quarterly, 2025-06-30) — Deferred Tax: 12106000.00
MD cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 5313000.00
MD income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 5313000.00
MD cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 5313000.00
MD income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 5313000.00
MD income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 86854234.00
MD income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.45
MD income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 39260000.00
MD income_statement (quarterly, 2025-06-30) — EBIT: 64099000.00
MD income_statement (quarterly, 2025-06-30) — EBITDA: 69412000.00
MD income_statement (quarterly, 2025-06-30) — Earnings From Equity Interest: 505000.00
MD cash_flow (quarterly, 2025-06-30) — End Cash Position: 224732000.00
MD cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -4259000.00
MD cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 132652000.00
MD income_statement (quarterly, 2025-06-30) — Gain On Sale Of Business: 0.00
MD income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 3727000.00
MD balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 137000.00
MD income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 55714000.00
MD balance_sheet (quarterly, 2025-06-30) — Goodwill: 1242606000.00
MD balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 1251902000.00
MD balance_sheet (quarterly, 2025-06-30) — Gross PPE: 77634000.00
MD income_statement (quarterly, 2025-06-30) — Gross Profit: 124728000.00
MD income_statement (quarterly, 2025-06-30) — Impairment Of Capital Assets: 0.00
MD balance_sheet (quarterly, 2025-06-30) — Income Tax Payable: 1949000.00
MD income_statement (quarterly, 2025-06-30) — Interest Expense: 9130000.00
MD income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 9130000.00
MD balance_sheet (quarterly, 2025-06-30) — Interest Payable: 8157000.00
MD balance_sheet (quarterly, 2025-06-30) — Invested Capital: 1441301000.00
MD cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -7154000.00
MD cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 1176000.00
MD cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 0.00
MD balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 29963000.00
MD balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 583863000.00
MD balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 613826000.00
MD cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -5192000.00
MD cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: 0.00
MD cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 967000.00
MD balance_sheet (quarterly, 2025-06-30) — Net Debt: 382816000.00
MD income_statement (quarterly, 2025-06-30) — Net Income: 39260000.00
MD income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 39260000.00
MD income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 39260000.00
MD income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 39260000.00
MD income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 39260000.00
MD cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 39260000.00
MD income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 39260000.00
MD income_statement (quarterly, 2025-06-30) — Net Interest Income: -9130000.00
MD cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: -2688000.00
MD cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -5192000.00
MD cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -5192000.00
MD income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -9130000.00
MD cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -34000.00
MD cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: 49000.00
MD balance_sheet (quarterly, 2025-06-30) — Net PPE: 77634000.00
MD cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -4515000.00
MD balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -418149000.00
MD balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 88729000.00
MD balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 36019000.00
MD balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 88729000.00
MD balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 36019000.00
MD income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 69519000.00
MD income_statement (quarterly, 2025-06-30) — Normalized Income: 39336398.00
MD cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 137167000.00
MD income_statement (quarterly, 2025-06-30) — Operating Income: 63701000.00
MD income_statement (quarterly, 2025-06-30) — Operating Revenue: 465634000.00
MD balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 86854234.00
MD balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 7678000.00
MD balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 23685000.00
MD balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 137000.00
MD income_statement (quarterly, 2025-06-30) — Other Gand A: 55714000.00
MD income_statement (quarterly, 2025-06-30) — Other Income Expense: 398000.00
MD balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 9296000.00
MD cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: -515000.00
MD balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 70785000.00
MD balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 277459000.00
MD balance_sheet (quarterly, 2025-06-30) — Other Properties: 77634000.00
MD balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 123594000.00
MD balance_sheet (quarterly, 2025-06-30) — Payables: 75391000.00
MD balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 305309000.00
MD balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
MD balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 10424000.00
MD income_statement (quarterly, 2025-06-30) — Pretax Income: 54969000.00
MD cash_flow (quarterly, 2025-06-30) — Purchase Of Business: 0.00
MD cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -13768000.00
MD cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -4515000.00
MD balance_sheet (quarterly, 2025-06-30) — Receivables: 246622000.00
MD income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 344116000.00
MD income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 5313000.00
MD cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -5192000.00
MD cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -209000.00
MD income_statement (quarterly, 2025-06-30) — Restructuring And Mergern Acquisition: 3834000.00
MD balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -188543000.00
MD cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 11080000.00
MD income_statement (quarterly, 2025-06-30) — Selling General And Administration: 55714000.00
MD balance_sheet (quarterly, 2025-06-30) — Share Issued: 86854234.00
MD income_statement (quarterly, 2025-06-30) — Special Income Charges: -3834000.00
MD cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 3909000.00
MD balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 833753000.00
MD balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -418149000.00
MD income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -30602.00
MD income_statement (quarterly, 2025-06-30) — Tax Provision: 15709000.00
MD income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.29
MD balance_sheet (quarterly, 2025-06-30) — Taxes Receivable: 7630000.00
MD balance_sheet (quarterly, 2025-06-30) — Total Assets: 2102100000.00
MD balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 1417616000.00
MD balance_sheet (quarterly, 2025-06-30) — Total Debt: 649560000.00
MD balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 833753000.00
MD income_statement (quarterly, 2025-06-30) — Total Expenses: 405143000.00
MD balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 1268347000.00
MD balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 1489050000.00
MD balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 927304000.00
MD income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 59867000.00
MD balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 33326000.00
MD income_statement (quarterly, 2025-06-30) — Total Unusual Items: -107000.00
MD income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -107000.00
MD balance_sheet (quarterly, 2025-06-30) — Working Capital: 272007000.00
MD income_statement (quarterly, 2025-09-30) — +Operating Expense: 66344000.00
MD income_statement (quarterly, 2025-09-30) — +Total Revenue: 492875000.00
MD balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 38652000.00
MD balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 231122000.00
MD balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 1006197000.00
MD cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: 0.00
MD income_statement (quarterly, 2025-09-30) — Basic Average Shares: 84609000.00
MD income_statement (quarterly, 2025-09-30) — Basic EPS: 0.85
MD cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 224732000.00
MD cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -5338000.00
MD balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 39759000.00
MD balance_sheet (quarterly, 2025-09-30) — Capital Stock: 858000.00
MD balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 340059000.00
MD balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 463101000.00
MD cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -28562000.00
MD cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 6604000.00
MD cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 138115000.00
MD cash_flow (quarterly, 2025-09-30) — Cash From Discontinued Operating Activities: -830000.00
MD cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 51118000.00
MD cash_flow (quarterly, 2025-09-30) — Change In Income Tax Payable: 4614000.00
MD cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: 7371000.00
MD cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -2545000.00
MD cash_flow (quarterly, 2025-09-30) — Change In Payable: 55732000.00
MD cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 55732000.00
MD cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -988000.00
MD cash_flow (quarterly, 2025-09-30) — Change In Receivables: 7870000.00
MD cash_flow (quarterly, 2025-09-30) — Change In Tax Payable: 4614000.00
MD cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 67440000.00
MD cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: 7870000.00
MD cash_flow (quarterly, 2025-09-30) — Changes In Cash: 115327000.00
MD balance_sheet (quarterly, 2025-09-30) — Common Stock: 858000.00
MD balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 890666000.00
MD cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 700000.00
MD cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -20867000.00
MD income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 352526000.00
MD balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 272304000.00
MD balance_sheet (quarterly, 2025-09-30) — Current Assets: 717195000.00
MD balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 12226000.00
MD balance_sheet (quarterly, 2025-09-30) — Current Debt: 25339000.00
MD balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 37565000.00
MD balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 392547000.00
MD cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 11135000.00
MD cash_flow (quarterly, 2025-09-30) — Deferred Tax: 11135000.00
MD cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 5551000.00
MD income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 5551000.00
MD cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 5551000.00
MD income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 5551000.00
MD income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 85613000.00
MD income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.84
MD income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 71708000.00
MD income_statement (quarterly, 2025-09-30) — EBIT: 96719000.00
MD income_statement (quarterly, 2025-09-30) — EBITDA: 102270000.00
MD income_statement (quarterly, 2025-09-30) — Earnings From Equity Interest: 1879000.00
MD cash_flow (quarterly, 2025-09-30) — End Cash Position: 340059000.00
MD cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -28562000.00
MD cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 131947000.00
MD cash_flow (quarterly, 2025-09-30) — Gain Loss On Sale Of Business: -20906000.00
MD income_statement (quarterly, 2025-09-30) — Gain On Sale Of Business: 20906000.00
MD income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: 5883000.00
MD balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 446000.00
MD income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 60793000.00
MD balance_sheet (quarterly, 2025-09-30) — Goodwill: 1255423000.00
MD balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 1270225000.00
MD balance_sheet (quarterly, 2025-09-30) — Gross PPE: 74338000.00
MD income_statement (quarterly, 2025-09-30) — Gross Profit: 140349000.00
MD income_statement (quarterly, 2025-09-30) — Impairment Of Capital Assets: 0.00
MD balance_sheet (quarterly, 2025-09-30) — Income Tax Payable: 2749000.00
MD income_statement (quarterly, 2025-09-30) — Interest Expense: 8941000.00
MD income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 8941000.00
MD balance_sheet (quarterly, 2025-09-30) — Interest Payable: 2780000.00
MD balance_sheet (quarterly, 2025-09-30) — Invested Capital: 1493174000.00
MD cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 6604000.00
MD cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 700000.00
MD cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 0.00
MD balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 27533000.00
MD balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 577169000.00
MD balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 604702000.00
MD cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -5190000.00
MD cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: 10804000.00
MD cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -20167000.00
MD balance_sheet (quarterly, 2025-09-30) — Net Debt: 262449000.00
MD income_statement (quarterly, 2025-09-30) — Net Income: 71708000.00
MD income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 71708000.00
MD income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 71708000.00
MD income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 71708000.00
MD income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 71708000.00
MD cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 71708000.00
MD income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 71708000.00
MD income_statement (quarterly, 2025-09-30) — Net Interest Income: -8941000.00
MD cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 1089000.00
MD cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -5190000.00
MD cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -5190000.00
MD income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -8941000.00
MD cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -3205000.00
MD cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: 49000.00
MD balance_sheet (quarterly, 2025-09-30) — Net PPE: 74338000.00
MD cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -5338000.00
MD balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -379559000.00
MD balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 79758000.00
MD balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 38285000.00
MD balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 79758000.00
MD balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 38285000.00
MD income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 81435000.00
MD income_statement (quarterly, 2025-09-30) — Normalized Income: 54685805.00
MD cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 137285000.00
MD income_statement (quarterly, 2025-09-30) — Operating Income: 74005000.00
MD income_statement (quarterly, 2025-09-30) — Operating Revenue: 489907000.00
MD balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 85832837.00
MD balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 10215000.00
MD balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 25339000.00
MD balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 446000.00
MD income_statement (quarterly, 2025-09-30) — Other Gand A: 60793000.00
MD income_statement (quarterly, 2025-09-30) — Other Income Expense: 22714000.00
MD balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 14802000.00
MD cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: -1963000.00
MD balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 57889000.00
MD balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 273205000.00
MD balance_sheet (quarterly, 2025-09-30) — Other Properties: 74338000.00
MD balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 123042000.00
MD balance_sheet (quarterly, 2025-09-30) — Payables: 82678000.00
MD balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 354982000.00
MD balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
MD balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 8942000.00
MD income_statement (quarterly, 2025-09-30) — Pretax Income: 87778000.00
MD cash_flow (quarterly, 2025-09-30) — Purchase Of Business: -19196000.00
MD cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -1955000.00
MD cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -5338000.00
MD balance_sheet (quarterly, 2025-09-30) — Receivables: 234937000.00
MD income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 352526000.00
MD income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 5551000.00
MD cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -5190000.00
MD cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -20867000.00
MD income_statement (quarterly, 2025-09-30) — Restructuring And Mergern Acquisition: 5954000.00
MD balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -116835000.00
MD cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 3044000.00
MD income_statement (quarterly, 2025-09-30) — Selling General And Administration: 60793000.00
MD balance_sheet (quarterly, 2025-09-30) — Share Issued: 85832837.00
MD income_statement (quarterly, 2025-09-30) — Special Income Charges: 14952000.00
MD cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 5150000.00
MD balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 890666000.00
MD balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -379559000.00
MD income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 3812805.00
MD income_statement (quarterly, 2025-09-30) — Tax Provision: 16070000.00
MD income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.18
MD balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 3815000.00
MD balance_sheet (quarterly, 2025-09-30) — Total Assets: 2199405000.00
MD balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 1467835000.00
MD balance_sheet (quarterly, 2025-09-30) — Total Debt: 642267000.00
MD balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 890666000.00
MD income_statement (quarterly, 2025-09-30) — Total Expenses: 418870000.00
MD balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 1308739000.00
MD balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 1482210000.00
MD balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 916192000.00
MD income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 68051000.00
MD balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 44026000.00
MD income_statement (quarterly, 2025-09-30) — Total Unusual Items: 20835000.00
MD income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 20835000.00
MD balance_sheet (quarterly, 2025-09-30) — Working Capital: 324648000.00
MD income_statement (annual, 2025-12-31) — +Operating Expense: 262618000.00
MD income_statement (quarterly, 2025-12-31) — +Operating Expense: 71311000.00
MD income_statement (annual, 2025-12-31) — +Total Revenue: 1913849000.00
MD income_statement (quarterly, 2025-12-31) — +Total Revenue: 493771000.00
MD balance_sheet (annual, 2025-12-31) — Accounts Payable: 37220000.00
MD balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 37220000.00
MD balance_sheet (annual, 2025-12-31) — Accounts Receivable: 229665000.00
MD balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 229665000.00
MD balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -132335000.00
MD balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -132335000.00
MD balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 947566000.00
MD balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 947566000.00
MD cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 0.00
MD cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 0.00
MD income_statement (annual, 2025-12-31) — Basic Average Shares: 82976110.00
MD income_statement (quarterly, 2025-12-31) — Basic Average Shares: 82976110.00
MD income_statement (annual, 2025-12-31) — Basic EPS: 1.99
MD income_statement (quarterly, 2025-12-31) — Basic EPS: 0.41
MD cash_flow (annual, 2025-12-31) — Beginning Cash Position: 229940000.00
MD cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 340059000.00
MD balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 8286000.00
MD balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 8286000.00
MD cash_flow (annual, 2025-12-31) — Capital Expenditure: -18458000.00
MD cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -5287000.00
MD balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 40662000.00
MD balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 40662000.00
MD balance_sheet (annual, 2025-12-31) — Capital Stock: 830000.00
MD balance_sheet (quarterly, 2025-12-31) — Capital Stock: 830000.00
MD balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 375241000.00
MD balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 375241000.00
MD balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 499723000.00
MD balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 499723000.00
MD cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -107494000.00
MD cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -68638000.00
MD cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -18296000.00
MD cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -10282000.00
MD cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 274739000.00
MD cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 114604000.00
MD cash_flow (annual, 2025-12-31) — Cash From Discontinued Operating Activities: -3648000.00
MD cash_flow (quarterly, 2025-12-31) — Cash From Discontinued Operating Activities: -502000.00
MD cash_flow (annual, 2025-12-31) — Change In Other Current Assets: 21798000.00
MD cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: 4826000.00
MD cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -34728000.00
MD cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -14702000.00
MD cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -1214000.00
MD cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 28332000.00
MD cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 57788000.00
MD cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -2920000.00
MD cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -2136000.00
MD cash_flow (annual, 2025-12-31) — Change In Receivables: 30558000.00
MD cash_flow (quarterly, 2025-12-31) — Change In Receivables: 1457000.00
MD cash_flow (annual, 2025-12-31) — Change In Working Capital: 41826000.00
MD cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 46019000.00
MD cash_flow (annual, 2025-12-31) — Changes In Account Receivables: 30558000.00
MD cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: 1457000.00
MD cash_flow (annual, 2025-12-31) — Changes In Cash: 145301000.00
MD cash_flow (quarterly, 2025-12-31) — Changes In Cash: 35182000.00
MD balance_sheet (annual, 2025-12-31) — Common Stock: 830000.00
MD balance_sheet (quarterly, 2025-12-31) — Common Stock: 830000.00
MD balance_sheet (annual, 2025-12-31) — Common Stock Equity: 865854000.00
MD balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 865854000.00
MD cash_flow (annual, 2025-12-31) — Common Stock Issuance: 3184000.00
MD cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 646000.00
MD cash_flow (annual, 2025-12-31) — Common Stock Payments: -86683000.00
MD cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -64038000.00
MD income_statement (annual, 2025-12-31) — Cost Of Revenue: 1420146000.00
MD income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 367787000.00
MD balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 342690000.00
MD balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 342690000.00
MD balance_sheet (annual, 2025-12-31) — Current Assets: 763514000.00
MD balance_sheet (quarterly, 2025-12-31) — Current Assets: 763514000.00
MD balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 13397000.00
MD balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 13397000.00
MD balance_sheet (annual, 2025-12-31) — Current Debt: 25000000.00
MD balance_sheet (quarterly, 2025-12-31) — Current Debt: 25000000.00
MD balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 38397000.00
MD balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 38397000.00
MD balance_sheet (annual, 2025-12-31) — Current Liabilities: 458911000.00
MD balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 458911000.00
MD cash_flow (annual, 2025-12-31) — Deferred Income Tax: 52186000.00
MD cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 24547000.00
MD cash_flow (annual, 2025-12-31) — Deferred Tax: 52186000.00
MD cash_flow (quarterly, 2025-12-31) — Deferred Tax: 24547000.00
MD cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 21827000.00
MD cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 5631000.00
MD income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 21827000.00
MD income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 5631000.00
MD cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 21827000.00
MD cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 5631000.00
MD income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 21827000.00
MD income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 5631000.00
MD income_statement (annual, 2025-12-31) — Diluted Average Shares: 85268000.00
MD income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 84415000.00
MD income_statement (annual, 2025-12-31) — Diluted EPS: 1.94
MD income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.40
MD income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 165388000.00
MD income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 33683000.00
MD income_statement (annual, 2025-12-31) — EBIT: 252397000.00
MD income_statement (quarterly, 2025-12-31) — EBIT: 54335000.00
MD income_statement (annual, 2025-12-31) — EBITDA: 274224000.00
MD income_statement (quarterly, 2025-12-31) — EBITDA: 59966000.00
MD income_statement (annual, 2025-12-31) — Earnings From Equity Interest: 3633000.00
MD income_statement (quarterly, 2025-12-31) — Earnings From Equity Interest: 843000.00
MD cash_flow (annual, 2025-12-31) — End Cash Position: 375241000.00
MD cash_flow (quarterly, 2025-12-31) — End Cash Position: 375241000.00
MD cash_flow (annual, 2025-12-31) — Financing Cash Flow: -107494000.00
MD cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -68638000.00
MD cash_flow (annual, 2025-12-31) — Free Cash Flow: 252633000.00
MD cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 108815000.00
MD cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of Business: -20906000.00
MD cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of Business: 0.00
MD income_statement (annual, 2025-12-31) — Gain On Sale Of Business: 20906000.00
MD income_statement (quarterly, 2025-12-31) — Gain On Sale Of Business: 0.00
MD income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 19045000.00
MD income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 4698000.00
MD balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 610000.00
MD balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 610000.00
MD income_statement (annual, 2025-12-31) — General And Administrative Expense: 240791000.00
MD income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 65680000.00
MD balance_sheet (annual, 2025-12-31) — Goodwill: 1260732000.00
MD balance_sheet (quarterly, 2025-12-31) — Goodwill: 1260732000.00
MD balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 1277594000.00
MD balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 1277594000.00
MD balance_sheet (annual, 2025-12-31) — Gross PPE: 205845000.00
MD balance_sheet (quarterly, 2025-12-31) — Gross PPE: 205845000.00
MD income_statement (annual, 2025-12-31) — Gross Profit: 493703000.00
MD income_statement (quarterly, 2025-12-31) — Gross Profit: 125984000.00
MD income_statement (annual, 2025-12-31) — Impairment Of Capital Assets: 0.00
MD income_statement (quarterly, 2025-12-31) — Impairment Of Capital Assets: 0.00
MD balance_sheet (annual, 2025-12-31) — Income Tax Payable: 984000.00
MD balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 984000.00
MD income_statement (annual, 2025-12-31) — Interest Expense: 35965000.00
MD income_statement (quarterly, 2025-12-31) — Interest Expense: 8740000.00
MD income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 35965000.00
MD income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 8740000.00
MD cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 34382000.00
MD balance_sheet (annual, 2025-12-31) — Interest Payable: 8151000.00
MD balance_sheet (quarterly, 2025-12-31) — Interest Payable: 8151000.00
MD balance_sheet (annual, 2025-12-31) — Invested Capital: 1459807000.00
MD balance_sheet (quarterly, 2025-12-31) — Invested Capital: 1459807000.00
MD cash_flow (annual, 2025-12-31) — Investing Cash Flow: -18296000.00
MD cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -10282000.00
MD cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 3184000.00
MD cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 646000.00
MD cash_flow (annual, 2025-12-31) — Issuance Of Debt: 0.00
MD cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 0.00
MD balance_sheet (annual, 2025-12-31) — Land And Improvements: 2032000.00
MD balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 2032000.00
MD balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 27265000.00
MD balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 27265000.00
MD balance_sheet (annual, 2025-12-31) — Long Term Debt: 568953000.00
MD balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 568953000.00
MD balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 596218000.00
MD balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 596218000.00
MD cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 0.00
MD cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 0.00
MD cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -20750000.00
MD cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -5341000.00
MD cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: 6804000.00
MD cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: -4000000.00
MD cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -83499000.00
MD cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -63392000.00
MD balance_sheet (annual, 2025-12-31) — Net Debt: 218712000.00
MD balance_sheet (quarterly, 2025-12-31) — Net Debt: 218712000.00
MD income_statement (annual, 2025-12-31) — Net Income: 165388000.00
MD income_statement (quarterly, 2025-12-31) — Net Income: 33683000.00
MD income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 165388000.00
MD income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 33683000.00
MD income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 165388000.00
MD income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 33683000.00
MD income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 165388000.00
MD income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 33683000.00
MD income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 165388000.00
MD income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 33683000.00
MD cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 165388000.00
MD cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 33683000.00
MD income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 165388000.00
MD income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 33683000.00
MD income_statement (annual, 2025-12-31) — Net Interest Income: -35965000.00
MD income_statement (quarterly, 2025-12-31) — Net Interest Income: -8740000.00
MD cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -3177000.00
MD cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -1117000.00
MD cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -20750000.00
MD cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -5341000.00
MD cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -20750000.00
MD cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -5341000.00
MD income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -35965000.00
MD income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -8740000.00
MD cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -3245000.00
MD cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: 95000.00
MD cash_flow (annual, 2025-12-31) — Net Other Investing Changes: -3465000.00
MD cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: 122000.00
MD balance_sheet (annual, 2025-12-31) — Net PPE: 73510000.00
MD balance_sheet (quarterly, 2025-12-31) — Net PPE: 73510000.00
MD cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -18458000.00
MD cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -5287000.00
MD balance_sheet (annual, 2025-12-31) — Net Tangible Assets: -411740000.00
MD balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -411740000.00
MD balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 73922000.00
MD balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 73922000.00
MD balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 57024000.00
MD balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 57024000.00
MD balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 73922000.00
MD balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 73922000.00
MD balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 57024000.00
MD balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 57024000.00
MD income_statement (annual, 2025-12-31) — Normalized EBITDA: 256545000.00
MD income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 61147000.00
MD income_statement (annual, 2025-12-31) — Normalized Income: 151877708.20